Výsledky vyhledávání - "Josephson NC"

Akademický článek

Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.

Autor: Johnsen JM; Research Institute, Bloodworks, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Fletcher SN; Research Institute, Bloodworks, Seattle, Washington, USA., Dove A; Research Institute, Bloodworks, Seattle, Washington, USA., McCracken H; Research Institute, Bloodworks, Seattle, Washington, USA., Martin BK; Genome Sciences, University of Washington, Seattle, Washington, USA., Kircher M; Genome Sciences, University of Washington, Seattle, Washington, USA., Josephson NC; Research Institute, Bloodworks, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Shendure J; Genome Sciences, University of Washington, Seattle, Washington, USA., Ruuska SE; Research Institute, Bloodworks, Seattle, Washington, USA., Valentino LA; National Hemophilia Foundation, New York, New York, USA., Pierce GF; National Hemophilia Foundation, New York, New York, USA., Watson C; American Thrombosis and Hemostasis Network, Rochester, New York, USA., Cheng D; American Thrombosis and Hemostasis Network, Rochester, New York, USA., Recht M; American Thrombosis and Hemostasis Network, Rochester, New York, USA., Konkle BA; Research Institute, Bloodworks, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Sep; Vol. 20 (9), pp. 2022-2034. Date of Electronic Publication: 2022 Jul 17.

Zobrazit plný text záznamu

Akademický článek

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.

Autor: Konkle BA; BloodWorks Northwest, Seattle, WA.; Division of Hematology, University of Washington School of Medicine, Seattle, WA., Walsh CE; Icahn School of Medicine at Mount Sinai, New York, NY., Escobar MA; McGovern Medical School and Gulf States Hemophilia and Thrombophilia Center, University of Texas Health Science Center Houston Medical School, Houston, TX., Josephson NC; Division of Hematology, University of Washington School of Medicine, Seattle, WA., Young G; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA., von Drygalski A; Hemophilia and Thrombosis Treatment Center, University of California, San Diego, CA., McPhee SWJ; Asklepios BioPharmaceutical and Chatham Therapeutics, Chapel Hill, NC., Samulski RJ; Gene Therapy Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC., Bilic I; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria; and., de la Rosa M; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria; and., Reipert BM; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria; and., Rottensteiner H; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria; and., Scheiflinger F; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria; and., Chapin JC; Baxalta US Inc., a member of the Takeda group of companies, Cambridge, MA., Ewenstein B; Baxalta US Inc., a member of the Takeda group of companies, Cambridge, MA., Monahan PE; Gene Therapy Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.; Baxalta US Inc., a member of the Takeda group of companies, Cambridge, MA.

Publikováno v: Blood [Blood] 2021 Feb 11; Vol. 137 (6), pp. 763-774.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání